Mechanism of Astragaloside IV in Treatment of Renal Tubulointerstitial Fibrosis | springermedicine.com

Springer Medicine

Chinese Journal of Integrative Medicine

Published in:

08-06-2024 | Review

Mechanism of Astragaloside IV in Treatment of Renal Tubulointerstitial Fibrosis

Authors: Xin-ru Wang, Jing-xiang Luan, Prof. Zhao-an Guo

Published in: Chinese Journal of Integrative Medicine | Issue 5/2025

Login to get access

Advertisement

Title: Mechanism of Astragaloside IV in Treatment of Renal Tubulointerstitial Fibrosis
Authors: Xin-ru Wang
Jing-xiang Luan
Prof. Zhao-an Guo
Publication date: 08-06-2024
Publisher: Springer Nature Singapore
Published in: Chinese Journal of Integrative Medicine / Issue 5/2025
Print ISSN: 1672-0415
Electronic ISSN: 1993-0402
DOI: https://doi.org/10.1007/s11655-024-3805-6

Other articles of this Issue 5/2025

Effect and Safety of Fuzheng Huazhuo Decoction against Prolonged SARS-CoV-2 Clearance: A Retrospective Cohort Study

Original Article

Efficacy and Safety of Erzhu Jiedu Decoction Granules in Treating Mid-advanced Hepatitis B Virus-Associated Primary Liver Cancer Patients with Pi (Spleen)-Deficiency and Dampness-Heat Syndrome

Original Article

Chrysophanol Induces Cell Death and Inhibits Invasiveness through Alteration of Calcium Levels in HepG2 Human Liver Cancer Cells

Original Article

Qingda Granule Attenuates Hypertension-Induced Cardiac Damage via Regulating Renin-Angiotensin System Pathway

Original Article

Mechanism of Reactive Oxygen/Nitrogen Species in Liver Ischemia-Reperfusion Injury and Preventive Effect of Chinese Medicine

Review

Astragaloside IV Alleviates Podocyte Injury in Diabetic Nephropathy through Regulating IRE-1α/NF-κ B/NLRP3 Pathway

Original Article